NCT00792324 Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125 Status COMPLETED Phase PHASE3
NCT00790959 The SASA! Study: An Evaluation of a Community Intervention to Address Gender-based Violence and Reduce HIV/AIDS Risk in Uganda Status UNKNOWN Phase NA
NCT00790881 Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults Status COMPLETED Phase PHASE4
NCT00789009 Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection Status RECRUITING Phase N/A
NCT00784147 Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1 Status COMPLETED Phase PHASE2
NCT00780260 Case Management Alternatives for African American Women at High Risk for HIV Status COMPLETED Phase PHASE3
NCT00775125 VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state. Status COMPLETED Phase PHASE1
NCT00774683 A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women Status COMPLETED Phase N/A
NCT00767312 Analysis of HIV-1 Replication During Antiretroviral Therapy Status ENROLLING_BY_INVITATION Phase N/A
NCT00767117 TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT00766818 The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet Status COMPLETED Phase PHASE1
NCT00765271 Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects Status COMPLETED Phase PHASE1
NCT00757783 Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment Status COMPLETED Phase PHASE4